Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Neonatal Arterial Morphology Is Related to Body Size in Abnormal Human Fetal Growth.

Olander RF, Sundholm JK, Ojala TH, Andersson S, Sarkola T.

Circ Cardiovasc Imaging. 2016 Sep;9(9). pii: e004657. doi: 10.1161/CIRCIMAGING.116.004657.

PMID:
27601367
2.

Feasibility and precision of transcutaneous very-high resolution ultrasound for quantification of arterial structures in human neonates - comparison with conventional high resolution vascular ultrasound imaging.

Sundholm JK, Olander RF, Ojala TH, Andersson S, Sarkola T.

Atherosclerosis. 2015 Apr;239(2):523-7. doi: 10.1016/j.atherosclerosis.2015.02.016. Epub 2015 Feb 16.

PMID:
25721703
3.

Immunity after (re)vaccination of paediatric patients following haematopoietic stem cell transplantation.

Olkinuora H, Käyhty H, Davidkin I, Roivainen M, Olander RM, Kantele JM, Siitonen S, Vettenranta K.

Acta Paediatr. 2012 Aug;101(8):e373-7. doi: 10.1111/j.1651-2227.2012.02710.x. Epub 2012 May 16.

PMID:
22537137
4.

Comparative seroepidemiology of diphtheria in six European countries and Israel.

di Giovine P, Kafatos G, Nardone A, Andrews N, Ölander RM, Alfarone G, Broughton K, Cohen D, Kriz B, Mikova I, O'Flanagan D, Schneider F, Selga I, Valinsky L, Velicko I, Karacs I, Pebody R, von Hunolstein C.

Epidemiol Infect. 2013 Jan;141(1):132-42. doi: 10.1017/S0950268812000210. Epub 2012 Feb 24.

PMID:
22361223
5.

Antibody responses to tetanus and diphtheria vaccine in chronic and recurrent rhinosinusitis.

Tahkokallio O, Koskinen A, Kentala E, Ölander RM, Mattila PS.

Rhinology. 2011 Mar;49(1):90-4. doi: 10.4193/Rhino10.005.

PMID:
21468381
6.

External quality assessment for the determination of diphtheria antitoxin in human serum.

Di Giovine P, Pinto A, Olander RM, Sesardic D, Stickings P, Berbers G, Neal S, Efstratiou A, Paberza R, Dauksiene S, Bujko M, Detcheva A, Joks U, Levent B, von Hunolstein C.

Clin Vaccine Immunol. 2010 Aug;17(8):1282-90. doi: 10.1128/CVI.00096-10. Epub 2010 Jul 7.

7.

Characteristics of drug and dietary supplement inquiries by college athletes.

Ambrose PJ, Tsourounis C, Olander R, Uryasz F.

Sports Health. 2010 Jan;2(1):12-8.

8.

High tetanus and diphtheria antitoxin concentrations in Finnish adults--time for new booster recommendations?

Olander RM, Auranen K, Härkänen T, Leino T.

Vaccine. 2009 Aug 27;27(39):5295-8. doi: 10.1016/j.vaccine.2009.06.080. Epub 2009 Jul 9. Review.

PMID:
19596410
9.

Bordetella pertussis isolates in Finland: serotype and fimbrial expression.

Heikkinen E, Xing DK, Olander RM, Hytönen J, Viljanen MK, Mertsola J, He Q.

BMC Microbiol. 2008 Sep 25;8:162. doi: 10.1186/1471-2180-8-162.

10.

A randomized study on donor immunization with tetanus-diphtheria, Haemophilus influenzae type b and inactivated poliovirus vaccines to improve the recipient responses to the same vaccines after allogeneic bone marrow transplantation.

Parkkali T, Käyhty H, Hovi T, Olander RM, Roivainen M, Volin L, Ruutu T, Lahdenkari M, Ruutu P.

Bone Marrow Transplant. 2007 Feb;39(3):179-88. Epub 2007 Jan 8.

PMID:
17211432
11.

Response and persistence of antibodies to PRP-T and DTwP vaccines with concomitant administration of conjugate vaccines.

Ocampo AF, Biltoft C, Lucero M, Olander RM, Ugpo J, Auranen K, Soininen A, Nohynek H, Käyhty H.

Vaccine. 2007 Jan 8;25(4):605-11. Epub 2006 Oct 12.

PMID:
17079058
12.

The seroepidemiology of Bordetella pertussis infection in Western Europe.

Pebody RG, Gay NJ, Giammanco A, Baron S, Schellekens J, Tischer A, Olander RM, Andrews NJ, Edmunds WJ, Lecoeur H, Lévy-Bruhl D, Maple PA, de Melker H, Nardone A, Rota MC, Salmaso S, Conyn-van Spaendonck MA, Swidsinski S, Miller E.

Epidemiol Infect. 2005 Feb;133(1):159-71.

13.

Treatment of hyperphosphatemia, secondary hyperparathyroidism and hypocalcemia with calcium carbonate favorably modulates vaccination response in uremic rats.

Hannula PM, Pörsti IH, Saha HH, Kalliovalkama J, Jolma PM, Kööbi P, Olander RM, Antonen JA.

Clin Nephrol. 2004 Jun;61(6):406-12.

PMID:
15224804
14.

European Sero-Epidemiology Network: standardisation of the assay results for pertussis.

Giammanco A, Chiarini A, Maple PA, Andrews N, Pebody R, Gay N, Olander RM, Fivet-Groyne F, Baron S, Tischer A, Swidsinski S, Schellekens J, Reizenstein E.

Vaccine. 2003 Dec 8;22(1):112-20.

PMID:
14604578
15.

Fatal case of diphtheria in an unvaccinated infant in Finland.

Lumio J, Suomalainen P, Olander RM, Saxén H, Salo E.

Pediatr Infect Dis J. 2003 Sep;22(9):844-6. No abstract available.

PMID:
14515838
16.

Health care utilization of chronic inebriates.

Thornquist L, Biros M, Olander R, Sterner S.

Acad Emerg Med. 2002 Apr;9(4):300-8.

17.

Epidemiology of three cases of severe diphtheria in Finnish patients with low antitoxin antibody levels.

Lumio J, Olander RM, Groundstroem K, Suomalainen P, Honkanen T, Vuopio-Varkila J.

Eur J Clin Microbiol Infect Dis. 2001 Oct;20(10):705-10.

PMID:
11757971
18.

Booster response to the tetanus and diphtheria toxoid carriers of 11-valent pneumococcal conjugate vaccine in adults and toddlers.

Olander RM, Wuorimaa T, Käyhty H, Leroy O, Dagan R, Eskola J.

Vaccine. 2001 Nov 12;20(3-4):336-41.

PMID:
11672895
19.

Response to vaccination against different types of antigens in patients with chronic lymphocytic leukaemia.

Sinisalo M, Aittoniemi J, Oivanen P, Käyhty H, Olander RM, Vilpo J.

Br J Haematol. 2001 Jul;114(1):107-10.

PMID:
11472353
20.

The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network.

Edmunds WJ, Pebody RG, Aggerback H, Baron S, Berbers G, Conyn-van Spaendonck MA, Hallander HO, Olander R, Maple PA, Melker HE, Olin P, Fievret-Groyne F, Rota C, Salmaso S, Tischer A, von-Hunolstein C, Miller E.

Epidemiol Infect. 2000 Aug;125(1):113-25. Erratum in: Epidemiol Infect 2001 Apr;126(2):331.

21.

The Pertussis Serological Potency Test. Collaborative study to evaluatereplacement of the Mouse Protection Test.

van der Ark A, van Straaten-van de Kappelle I, Olander RM, Enssle K, Jadhav S, van de Donk H, Hendriksen C.

Biologicals. 2000 Jun;28(2):105-18.

PMID:
10885617
22.

European sero-epidemiology network: standardisation of the results of diphtheria antitoxin assays.

von Hunolstein C, Aggerbeck H, Andrews N, Berbers G, Fievet-Groyne F, Maple PA, Olander RM, Raux M, Tischer A.

Vaccine. 2000 Aug 1;18(28):3287-96.

PMID:
10869774
23.

Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.

Vesikari T, Joensuu J, Baer M, Käyhty H, Olander RM, Sormunen H, Miettinen A, Ward RL, Guillot T.

Acta Paediatr. 1999 May;88(5):513-20.

PMID:
10426173
24.

B and T cell immunity in patients with lysinuric protein intolerance.

Lukkarinen M, Parto K, Ruuskanen O, Vainio O, Käyhty H, Olander RM, Simell O.

Clin Exp Immunol. 1999 Jun;116(3):430-4.

25.

Cell-mediated immune responses to antigens of Bordetella pertussis and protection against pertussis in school children.

Tran Minh NN, He Q, Edelman K, Olander RM, Viljanen MK, Arvilommi H, Mertsola J.

Pediatr Infect Dis J. 1999 Apr;18(4):366-70.

PMID:
10223692
26.

Plasma exchange or immunoadsorption in patients with rapidly progressive crescentic glomerulonephritis. A Swedish multi-center study.

Stegmayr BG, Almroth G, Berlin G, Fehrman I, Kurkus J, Norda R, Olander R, Sterner G, Thysell H, Wikström B, Wirén JE.

Int J Artif Organs. 1999 Feb;22(2):81-7.

PMID:
10212042
28.

Effect of transplacentally acquired tetanus antibodies on the antibody responses to Haemophilus influenzae type b-tetanus toxoid conjugate and tetanus toxoid vaccines in Filipino infants.

Nohynek H, Gustafsson L, Capeding MR, Käyhty H, Olander RM, Pascualk L, Ruutu P.

Pediatr Infect Dis J. 1999 Jan;18(1):25-30.

PMID:
9951976
29.

A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMT.

Parkkali T, Olander RM, Ruutu T, Vuontela K, Volin L, Eskola J, Ruutu P.

Bone Marrow Transplant. 1997 May;19(9):933-8.

30.

Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine.

Eskola J, Olander RM, Hovi T, Litmanen L, Peltola S, Käyhty H.

Lancet. 1996 Dec 21-28;348(9043):1688-92.

PMID:
8973430
31.
32.

Loss of protective immunity to polio, diphtheria and Haemophilus influenzae type b after allogeneic bone marrow transplantation.

Parkkali T, Ruutu T, Stenvik M, Kuronen T, Käyhty H, Hovi T, Olander RM, Volin L, Ruutu P.

APMIS. 1996 May;104(5):383-8.

PMID:
8703445
34.

[Vaccine against Haemophilus influenzae type b--antibody response and adverse effects].

Nøkleby H, Sandbu S, Käyhty H, Olander RM, Heilmann C.

Tidsskr Nor Laegeforen. 1995 May 20;115(13):1604-6. Norwegian.

PMID:
7778073
35.

Coronary artery bypass graft surgery in patients with poor left ventricular performance: results in a community hospital. Lincoln Heart Failure Treatment Program.

Krueger SK, Wilson CS, Hedderich GS, Olander RK, Ayala KN, Jex RK, Caudill CC, Gangahar DM, Raines EP.

Nebr Med J. 1995 Apr;80(4):77-9. No abstract available.

PMID:
7777096
36.

Antibodies to filamentous hemagglutinin of Bordetella pertussis and protection against whooping cough in schoolchildren.

He Q, Viljanen MK, Olander RM, Bogaerts H, De Grave D, Ruuskanen O, Mertsola J.

J Infect Dis. 1994 Sep;170(3):705-8.

PMID:
8077734
37.

A new argon laser suture lysis lens.

Mandelkorn RM, Crossman JL, Olander RW, Heacock G.

Ophthalmic Surg. 1994 Jul;25(7):480-1. No abstract available.

PMID:
7970524
38.

[Reasons for diphtheria vaccination campaign].

Eskola J, Olander RM, Kuronen T.

Duodecim. 1994;110(4):449. Finnish. No abstract available.

PMID:
7555836
39.

[Is extensive diphtheria vaccination necessary?].

Eskola J, Olander RM, Kuronen T.

Duodecim. 1994;110(1):11-2. Finnish. No abstract available.

PMID:
7555743
40.

Biological activities of lipoteichoic acid and peptidoglycan-teichoic acid of Bacillus subtilis 168 (Marburg).

Himanen JP, Pyhälä L, Olander RM, Merimskaya O, Kuzina T, Lysyuk O, Pronin A, Sanin A, Helander IM, Sarvas M.

J Gen Microbiol. 1993 Nov;139(11):2659-65.

PMID:
8277249
41.

The role of the O antigen in adjuvant activity of lipopolysaccharide.

Nurminen M, Olander RM.

FEMS Microbiol Lett. 1991 Sep 15;67(1):51-4.

PMID:
1778421
42.

The 20 kDa C-terminally truncated form of pertussis toxin subunit S1 secreted from Bacillus subtilis.

Himanen JP, Hyvärinen T, Olander RM, Runeberg-Nyman K, Sarvas M.

FEMS Microbiol Lett. 1991 Mar 15;63(1):115-20.

PMID:
1904382
43.

Immunogenicity and protective efficacy of pertussis toxin subunit S1 produced by Bacillus subtilis.

Olander RM, Muotiala A, Himanen JP, Karvonen M, Airaksinen U, Runeberg-Nyman K.

Microb Pathog. 1991 Feb;10(2):159-64.

PMID:
1909767
44.

An ectopic rim sign in hepatobiliary scintigraphy.

Haygood TM, Olander RL, Mosdell D, Eisenberg B.

Am J Physiol Imaging. 1991;6(2):62-4.

PMID:
1867864
45.

[A case of Goodpasture's syndrome. Myeloperoxidase antibodies as a valuable serological marker in vasculitis].

Olander R, Samuelsson I, Danielsson D.

Lakartidningen. 1990 Oct 17;87(42):3406-7. Swedish. No abstract available.

PMID:
2172672
46.

Iron dextran: bone imaging patterns of absorption--a case report.

Eisenberg B, Meholic AJ, Arrington ER, Elliott TM, Wiest PW, Olander RL.

Am J Physiol Imaging. 1990;5(3):116-8.

PMID:
2285521
47.
48.

Controlled trial of acupuncture for severe recidivist alcoholism.

Bullock ML, Culliton PD, Olander RT.

Lancet. 1989 Jun 24;1(8652):1435-9.

PMID:
2567439
49.

Acupuncture treatment of alcoholic recidivism: a pilot study.

Bullock ML, Umen AJ, Culliton PD, Olander RT.

Alcohol Clin Exp Res. 1987 Jun;11(3):292-5.

PMID:
3307496
50.

Protective activities of "Bordetella pertussis" Tn5 mutants in mice.

Olander RM, Muotiala A, Parviainen T, Runeberg-Nyman K.

Ann Sclavo Collana Monogr. 1986;3(1-2):329-35. No abstract available.

PMID:
2892513

Supplemental Content

Loading ...
Support Center